Targeting glycosylated PD-L1 to enhance patients’ anti-cancer immune response
GeneTex webinar on the role of PD-L1 in cancer therapy
![GeneTex webinar on the role of PD-L1 in cancer therapy GeneTex webinar on the role of PD-L1 in cancer therapy](https://www.lubio.ch/assets/_processed_/9/5/csm_GeneTex_2020_PD-L1_webinar_slide_EU_88e562ad4f.jpg)
Date and time:
Thursday, November 19th, 2 p.m.- 3 p.m. (CET)
Speaker:
Dr. Chia-Wei Li (Assistant researcher)
Objectives:
- Immunity and cancers
- Glycosylation of programmed death-ligand 1 (PD-L1)
- Cancer therapies
- GeneTex’s featured products